000683 reported revenue of ¥6.03B for the period ended 2026-06-30, +1.9% year on year. Net income was ¥1.09B, a 18.1% net margin on a 29.2% gross margin. The largest revenue line is 纯碱 at 66% of the total.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.03B | +1.9% |
| Gross profit | ¥1.76B | — |
| Operating income | ¥1.28B | — |
| Net income | ¥1.09B | +1.3% |
| Gross margin | 29.2% | Net margin 18.1% |
| Revenue Q/Q | +21.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 纯碱 | ¥3.99B | 66.1% |
| 尿素 | ¥1.24B | 20.5% |
| 小苏打 | ¥0.70B | 11.7% |
| 其他产品 | ¥0.08B | 1.3% |
| 其他(补充) | ¥0.02B | 0.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.27B | 70.8% |
| R&D | ¥0.04B | 0.6% |
| SG&A | ¥0.41B | 6.8% |
| Tax & other | ¥0.18B | 3.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万科A ・ 中兴通讯 ・ TCL科技 ・ 中联重科 ・ 申万宏源 ・ 东方盛虹 ・ 美的集团 ・ 潍柴动力 ・ 藏格矿业 ・ 徐工机械 ・ 云南白药 ・ 泸州老窖
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies